These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29237589)

  • 21. [Hypertrophic cardiomyopathy -- modern state of the problem. Issues of epidemiology and nomenclature, genetics and pathophysiology, variants of course and differential diagnosis].
    Belenkov IuN; Privalova EV; Kaplunova VIu; Khabarova NV; Shakar'iants GA
    Kardiologiia; 2013; 53(5):4-12. PubMed ID: 23952988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lifestyle Modification and Medical Management of Hypertrophic Cardiomyopathy.
    Heitner SB; Fischer KL
    Cardiol Clin; 2019 Feb; 37(1):45-54. PubMed ID: 30447715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-dependent pathophysiological mechanisms in hypertrophic cardiomyopathy: implications for rhythm disorders.
    Nijenkamp LL; Güçlü A; Appelman Y; van der Velden J; Kuster DW
    Heart Rhythm; 2015 Feb; 12(2):433-9. PubMed ID: 25446151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary hypertension in hypertrophic cardiomyopathy: a forgotten marker in the identification of candidates to surgical myectomy?
    Spirito P; Ferrazzi P
    Eur Heart J Cardiovasc Imaging; 2016 Jun; 17(6):611-2. PubMed ID: 27076361
    [No Abstract]   [Full Text] [Related]  

  • 25. Predictors of syncope in patients with hypertrophic cardiomyopathy.
    Haghjoo M; Faghfurian B; Taherpour M; Fazelifar AF; Mohammadzadeh S; Alizadeh A; Sadr-Ameli MA
    Pacing Clin Electrophysiol; 2009 May; 32(5):642-7. PubMed ID: 19422586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertrophic cardiomyopathy with mitral inflow obstruction and severe pulmonary hypertension.
    Moorthy N; Jain S; Kumar S; Goel PK
    Circulation; 2013 Aug; 128(8):870-2. PubMed ID: 23960259
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hypertrophic cardiomyopathy: current state of the problem].
    Lednev PV; Stonogin AV; Lysenko AV; Salagaev GI; Belov YV
    Khirurgiia (Mosk); 2019; (1):83-88. PubMed ID: 30789614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease.
    Charron P; Komajda M
    Expert Rev Mol Diagn; 2006 Jan; 6(1):65-78. PubMed ID: 16359268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Misconceptions and Facts About Hypertrophic Cardiomyopathy.
    Argulian E; Sherrid MV; Messerli FH
    Am J Med; 2016 Feb; 129(2):148-52. PubMed ID: 26299316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the prevalence, clinical features, and long-term outcomes of midventricular hypertrophy vs apical phenotype in patients with hypertrophic cardiomyopathy.
    Cai C; Duan FJ; Yang YJ; Guo XY; Liu YL; Liu YQ; Yan LR; Xu ZM; Zhao SH; Hua W; Li YS; Fan CM
    Can J Cardiol; 2014 Apr; 30(4):441-7. PubMed ID: 24468417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity and hypertrophic cardiomyopathy: chickens, eggs, and causality: clinical skills remain the key to caring for patients.
    Ommen SR; Lopez-Jimenez F
    J Am Coll Cardiol; 2013 Jul; 62(5):458-9. PubMed ID: 23643594
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypertrophic cardiomyopathy in China.
    Maron BJ
    Am J Cardiol; 2007 Jul; 100(1):145-6. PubMed ID: 17599458
    [No Abstract]   [Full Text] [Related]  

  • 33. Genotype-phenotype Correlations of Hypertrophic Cardiomyopathy When Diagnosed in Children, Adolescents, and Young Adults.
    Loar RW; Bos JM; Will ML; Ommen SR; Ackerman MJ
    Congenit Heart Dis; 2015; 10(6):529-36. PubMed ID: 26061417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertrophic cardiomyopathy in the developing world: focus on India.
    Maron BJ; Kalra A
    Eur Heart J; 2014 Sep; 35(36):2492-5. PubMed ID: 25038775
    [No Abstract]   [Full Text] [Related]  

  • 35. [Epidemiology of dilated cardiomyopathy and hypertrophic cardiomyopathy].
    Kibira S; Miura M
    Nihon Rinsho; 2000 Jan; 58(1):141-6. PubMed ID: 10885302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and echocardiographic study of hypertrophic cardiomyopathy in Tanzania.
    Maro EE; Janabi M; Kaushik R
    Trop Doct; 2006 Oct; 36(4):225-7. PubMed ID: 17034699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history.
    Maron BJ; Spirito P
    Am J Cardiol; 1993 Oct; 72(12):970-2. PubMed ID: 8213558
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypertrophic cardiomyopathy.
    Shah M
    Cardiol Young; 2017 Jan; 27(S1):S25-S30. PubMed ID: 28084957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient characteristics and incidence of childhood hospitalisation due to hypertrophic cardiomyopathy in the United States of America 2001-2014.
    Sakai-Bizmark R; Webber EJ; Marr EH; Mena LA; Chang RR
    Cardiol Young; 2019 Mar; 29(3):344-354. PubMed ID: 30907336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertrophic cardiomyopathy in China: three decades of progress.
    Cheng TO
    Int J Cardiol; 2005 Apr; 100(3):493-4. PubMed ID: 15837095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.